INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 111 filers reported holding INHIBRX INC in Q3 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,926,256 | -55.0% | 159,469 | -36.3% | 0.00% | 0.0% |
| Q2 2023 | $6,500,825 | +96.7% | 250,417 | +42.9% | 0.00% | 0.0% |
| Q1 2023 | $3,305,665 | -22.1% | 175,181 | +1.7% | 0.00% | 0.0% |
| Q4 2022 | $4,243,500 | +52.2% | 172,220 | +10.9% | 0.00% | 0.0% |
| Q3 2022 | $2,788,000 | +205.0% | 155,304 | +93.1% | 0.00% | – |
| Q2 2022 | $914,000 | -71.6% | 80,447 | -44.3% | 0.00% | -100.0% |
| Q1 2022 | $3,219,000 | -39.6% | 144,479 | +18.4% | 0.00% | 0.0% |
| Q4 2021 | $5,330,000 | -2.7% | 122,066 | -25.8% | 0.00% | 0.0% |
| Q3 2021 | $5,480,000 | +285.9% | 164,533 | +219.0% | 0.00% | – |
| Q2 2021 | $1,420,000 | +66.1% | 51,582 | +21.1% | 0.00% | – |
| Q1 2021 | $855,000 | +107.0% | 42,584 | +240.2% | 0.00% | – |
| Q4 2020 | $413,000 | -74.4% | 12,517 | -86.1% | 0.00% | – |
| Q3 2020 | $1,615,000 | – | 89,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,286,435 | $31,697,758 | 8.22% |
| Perceptive Advisors | 3,313,783 | $81,651,613 | 2.29% |
| RA Capital Management | 3,853,867 | $94,959,283 | 1.93% |
| Soleus Capital Management, L.P. | 478,302 | $11,785,361 | 1.69% |
| Sofinnova Investments, Inc. | 1,110,183 | $27,354,909 | 1.62% |
| Birchview Capital, LP | 70,448 | $1,736 | 1.23% |
| VIKING GLOBAL INVESTORS LP | 6,639,199 | $163,589,863 | 0.82% |
| Meridian Wealth Advisors, LLC | 122,315 | $3,013,842 | 0.78% |
| Gyon Technologies Capital Management, LP | 44,074 | $1,085,983 | 0.41% |
| ArrowMark Colorado Holdings LLC | 1,139,337 | $28,073,264 | 0.34% |